A detailed history of Optimum Investment Advisors transactions in Moderna, Inc. stock. As of the latest transaction made, Optimum Investment Advisors holds 904 shares of MRNA stock, worth $33,312. This represents 0.03% of its overall portfolio holdings.

Number of Shares
904
Previous 1,384 34.68%
Holding current value
$33,312
Previous $164,000 63.41%
% of portfolio
0.03%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$63.64 - $125.14 $30,547 - $60,067
-480 Reduced 34.68%
904 $60,000
Q2 2024

Jul 12, 2024

SELL
$101.21 - $166.61 $10,627 - $17,494
-105 Reduced 7.05%
1,384 $164,000
Q1 2024

Apr 11, 2024

BUY
$85.37 - $115.44 $17,074 - $23,088
200 Added 15.52%
1,489 $158,000
Q4 2023

Jan 08, 2024

SELL
$69.51 - $104.43 $13,902 - $20,886
-200 Reduced 13.43%
1,289 $128,000
Q2 2023

Aug 03, 2023

SELL
$118.5 - $160.53 $24,885 - $33,711
-210 Reduced 12.36%
1,489 $180,000
Q1 2023

May 03, 2023

SELL
$135.66 - $197.02 $44,089 - $64,031
-325 Reduced 16.06%
1,699 $260,000
Q3 2022

Oct 24, 2022

SELL
$118.07 - $194.18 $23,614 - $38,836
-200 Reduced 8.99%
2,024 $239,000
Q2 2022

Jul 12, 2022

SELL
$117.13 - $176.59 $11,713 - $17,659
-100 Reduced 4.3%
2,224 $318,000
Q1 2022

Apr 08, 2022

SELL
$126.46 - $235.05 $12,646 - $23,505
-100 Reduced 4.13%
2,324 $400,000
Q4 2021

Mar 17, 2022

BUY
$225.82 - $368.51 $495,449 - $808,510
2,194 Added 953.91%
2,424 $616,000
Q3 2021

Oct 22, 2021

SELL
$221.9 - $484.47 $37,723 - $82,359
-170 Reduced 42.5%
230 $89,000
Q2 2021

Aug 02, 2021

BUY
$129.91 - $234.98 $6,495 - $11,749
50 Added 14.29%
400 $94,000
Q1 2021

Apr 15, 2021

BUY
$109.18 - $185.98 $38,213 - $65,093
350 New
350 $46,000
Q2 2020

Jul 16, 2020

SELL
$29.67 - $80.0 $11,868 - $32,000
-400 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$17.78 - $31.58 $7,112 - $12,632
400 New
400 $12,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.